Technology Report Cyprus: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Report Cyprus.

Press releases published on September 9, 2026

19 minutes ago

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Indeterminate GlobeNewswire

25 minutes ago

American Academy of Neurology onboards Marvix AI to its Practice Success Network to bring ambient AI to thousands of neurologists

Indeterminate GlobeNewswire

32 minutes ago

Rail Vision Introduces TrackScout and YardFlow Flex as New Brand Names for its Mainline and Switchyard Solutions

Indeterminate GlobeNewswire

34 minutes ago

NervGen to Host Inaugural R&D Day on September 30, 2026

Indeterminate GlobeNewswire

34 minutes ago

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

Indeterminate GlobeNewswire

34 minutes ago

Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada

Indeterminate GlobeNewswire

an hour ago

Kane Biotech to Host Commercial Update Webcast on September 16

Indeterminate GlobeNewswire

an hour ago

Bilibili Inc. Announces Completion of US$500 Million Marketed Convertible Senior Notes Offering, Concurrent Equity Placement and Concurrent Delta Repurchase

Indeterminate GlobeNewswire

an hour ago

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

an hour ago

Remix Therapeutics Appoints Nicole Sweeny as Chief Commercial Officer

Indeterminate GlobeNewswire

an hour ago

Accumulus Technologies Announces Acquisition by Eir Partners to Accelerate Next Phase of Growth

Indeterminate GlobeNewswire

an hour ago

Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247

Indeterminate GlobeNewswire

an hour ago

SailPoint Announces Fiscal Second Quarter 2027 Results

Indeterminate GlobeNewswire

an hour ago

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire

an hour ago

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

Indeterminate GlobeNewswire

an hour ago

Solstice Oncology Launches with $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

Indeterminate GlobeNewswire

an hour ago

Beeline Medicines Announces Positive Topline Results from Global Phase 2 Study of Afimetoran in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire

an hour ago

Xanadu and ASML Announce Collaboration to Advance Lithography for Photonic Quantum Hardware

Indeterminate GlobeNewswire

an hour ago

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Indeterminate GlobeNewswire

an hour ago

Broncos Country, This One’s for You: Breckenridge Distillery Kicks Off Another Season with the Denver Broncos and a Limited-Edition Whiskey Collection Honoring “The Drive”

Indeterminate GlobeNewswire